Everand Logo

Welcome to Everand!

  • STAT

    ‘It is a bit uncomfortable’: Before the criminal allegations, an awards program honored Insys and Theranos

    “It is a bit uncomfortable to have them on the list,” acknowledged Joan Koerber-Walker, president and CEO of the Arizona BioIndustry Association, whose past honorees include Insys and Theranos.
    by Rebecca Robbins May 08, 2019 3 minutes
    Arizona State Route 202, Red Mountain Freeway, near Phoenix Sky Harbor International Airport.

    When it comes to having a bad corporate reputation, it doesn’t get much worse than Insys Therapeutics and Theranos.

    Last week, five former Insys executives, including founder John Kapoor, were found guilty of racketeering in pushing the company’s powerful opioid; jurors said they were horrified when they saw a music video, produced to pump up sales, featuring two Insys salesmen rapping about ramping up the dose of the painkiller. Meanwhile, ex-Theranos

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
    To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.
    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
    Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.

    Related Books & Audiobooks